ASTM F2347 - 11

    Standard Guide for Characterization and Testing of Hyaluronan as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications

    Active Standard ASTM F2347 | Developed by Subcommittee: F04.42

    Book of Standards Volume: 13.01


      Format Pages Price  
    PDF Version 10 $42.00   ADD TO CART
    Print Version 10 $42.00   ADD TO CART
    Standard + Redline PDF Bundle 20 $50.40   ADD TO CART


    Significance and Use

    This guide contains a listing of those characterization parameters that are directly related to the functionality of hyaluronan. This guide can be used as an aid in the selection and characterization of the appropriate hyaluronan for a particular application. This guide is intended to give guidance in the methods and types of testing necessary to properly characterize, assess, and ensure consistency in the performance of a particular hyaluronan. It may have use in the regulation of these devices by appropriate authorities.

    The hyaluronan covered by this guide may be gelled, cross-linked, extruded, or otherwise formulated into biomedical devices for use in tissue engineered medical products or drug delivery devices for implantation as determined to be appropriate, based on supporting biocompatibility and physical test data. Recommendations in this guide should not be interpreted as a guarantee of clinical success in any tissue engineered medical product or drug delivery application.

    To ensure that the material supplied satisfies requirements for use in TEMPs, several general areas of characterization should be considered. These are: identity of hyaluronan, physical and chemical characterization and testing, impurities profile, and performance-related tests.

    1. Scope

    1.1 This guide covers the evaluation of hyaluronan suitable for use in biomedical or pharmaceutical applications, or both, including, but not limited to, Tissue Engineered Medical Products (TEMPs).

    1.2 This guide addresses key parameters relevant to the characterization and purity of hyaluronan.

    1.3 As with any material, some characteristics of hyaluronan may be altered by processing techniques, such as cross-linking and sterilization, required for the production of a specific formulation or device. Therefore, properties of fabricated forms of this polymer should be evaluated using test methods that are appropriate to ensure safety and efficacy and are not addressed in this guide.

    1.4 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

    1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory requirements prior to use.


    2. Referenced Documents (purchase separately) The documents listed below are referenced within the subject standard but are not provided as part of the standard.

    ASTM Standards

    D2196 Test Methods for Rheological Properties of Non-Newtonian Materials by Rotational (Brookfield type) Viscometer

    F619 Practice for Extraction of Medical Plastics

    F748 Practice for Selecting Generic Biological Test Methods for Materials and Devices

    F749 Practice for Evaluating Material Extracts by Intracutaneous Injection in the Rabbit

    F756 Practice for Assessment of Hemolytic Properties of Materials

    F763 Practice for Short-Term Screening of Implant Materials

    F813 Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices

    F895 Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity

    F981 Practice for Assessment of Compatibility of Biomaterials for Surgical Implants with Respect to Effect of Materials on Muscle and Bone

    F1251 Terminology Relating to Polymeric Biomaterials in Medical and Surgical Devices

    F1439 Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials

    F1903 Practice for Testing For Biological Responses to Particles In Vitro

    F1904 Practice for Testing the Biological Responses to Particles in vivo

    F1905 Practice For Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity

    F1906 Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte Proliferation, and Cell Migration


    ICS Code

    ICS Number Code 11.120.99 (Other standards related to pharmaceutics)

    UNSPSC Code

    UNSPSC Code


    DOI: 10.1520/F2347-11

    ASTM International is a member of CrossRef.

    ASTM F2347

    Citing ASTM Standards
    Back to Top